Prof. Dr. med. Dr. h.c.
Peter Schemmer
Chirurgo della Clinica del Pancreas Svizzera
Expertise of Prof. Dr. med. Dr. h.c. Peter Schemmer
Prof. Dr. med. Dr. h.c. Peter Schemmer is internationally well recognized for his great surgical expertise. He has devoted himself to surgical oncology of the abdominal organs. While he performs general, endocrine, upper and lower gastrointestinal surgery his special interest is hepato-pancreato-biliary surgery for diseases of both the liver and the pancreas. Especially in this field he developed surgical procedures that are used worldwide. He prioritiezes modern minimal invasive (laparoscopic, robotic assisted) procedures if applicable. To date he performed more than 7.300 mostly highly complex operations.
He has been awared several honorary professorships and doctorates worldwide for both his clinical and scientific impact. Prof. Schemmer has co-authored more than 750 publications and has been cited more than 18.000 times.
Qualifications and specialisations
Since 2016
Fellow of the American College of Surgeons (FACS)
2011
Surgical Intensive Care Medicine (Board certified)
2008
Visceral Surgeon (Board certified)
2004
Postdoctoral Lecture Qualification (Habilitation, Ph.D. equivalent), Ruprecht-Karls-University Heidelberg, Germany
2002
General Surgeon (Board certified)
1996 – 1998
Fellowship, University of North Carolina, Chapel Hill, USA
1996
Doctorate in Medicine (Dr. med.), Justus-Liebig-University Gießen, Germany
1994
Medical License, Justus-Liebig-University Gießen, Germany
1988 – 1994
Study of Medicine (Justus-Liebig-University Gießen, Germany; Memorial University of Newfoundland; Canada, Ohio State University, USA)
Medical practice
Since 2023
Leading Surgeon, Pancreas Clinic Switzerland
Leading Surgeon, Bern Visceral Surgery
Hirslanden Clinic Beau-Site, Bern
Since 2019
Head and owner of the Practice for General and Viszeral Surgery, Graz, Austria
Since 2019
Medical Counsellor, Shulan (Hangzhou) Hospital, People’s Republic of China
2019 – 2022
Surgical instructor and consultant for both liver and pancreatic surgery, Department of Surgery, State Hospital Hochsteiermark, Leoben, Austria
2016 – 2023
Department of Surgery, State Hospital – University Hospital Graz, Medical University Graz, Austria
Full Professor of Surgery
Chairman, Division of General, Visceral and Transplant Surgery
Chairman, Division of Transplant Surgery
2016
Chairman, Department of General and Visceral Surgery, Barmherzige Schwestern Hospital, Linz, Austria
1994 – 2016
Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Germany
2013 – 2016
Vice Chairman
2012 – 2016
Executive / Managing Senior Physician
2011 – 2016
Head of Section, Transplant Surgery (kidney, pancreas, liver)
2010 – 2016
Head of Section, Liver Surgery
2007 – 2012
First Attending
2003 – 2006
Consultant
1994 – 2003
Surgical Resident
In offices and boards of directors
Since 2021
World Journal of Gastrointestinal Surgery
Editor-in-Chief
2019 – 2021
Scientific Society of Styrian Physicians
Vice President (2019 – 2020), President (2020 – 2021)
Since 2018
Annals of Medicine and Surgery
Assistant Editor
2018
United Nations Development Programme (UNDP)
Consultant
2017 – 2024
Austrian Society of Surgical Research
Scientific Committee
Since 2017
German Academy for Transplantation Medicine
Board Member
Since 2017
European Surgery – Acta Chirurgica Austriaca
Section Editor
2016 – 2023
Austrian Transplantation Society
Extended board of directors
2016 – 2018
The Japanese-German Society for the Study of Liver Surgery
President
Since 2016
Istanbul Gastrointestinal Surgery Society
Honorary member
Since 2015
Langenbeck’s Archives of Surgery
Associate Editor
2015 – 2023
Medical Advisor in ministries
Austrian Federal Institute of Health
Transplant Advisory Board (2017 – 2023)
German Ministry of Health
Deployed by the German Society of Surgery (2015 – 2016)
Since 2012
Lithuanian Association of Transplantologists
Honorary Member
2012 – 2022
German Society of Surgery
Priority Funding
Spokesperson / Coordinator (2012 – 2016)
Creation of the S3 guideline liver transplantation
Representative of the German Society of Surgery and the German Society of General and Visceral Surgery (2016 – 2022)
2012 – 2016
Liver Cancer Center Heidelberg (LCCH)
Member of the governing body
2013 – 2023
German Transplantation Society (DTG)
Member of the extended board and commission chairman
2011 – 2023
Federal Advisory Board of the German Organ Transplantation Foundation (DSO)
Representative of the German Transplantation Society
2011 – 2022
German Society of General and Visceral Surgery (DGAV)
Surgical Working Group Transplantation
Chairman (2011 – 2018)
Creation of the liver transplant guideline
Elected official (2016 – 2022)
Delphi process for guidelines in liver transplantation
Appointed expert (2021 – 2022)
Since 2008
Reviewer for research funding organizations
German Research Foundation (DFG), Bonn, Germany
Institut National du Cancer, Paris, France
Medical Research Council / UK Research & Innovation, London, United Kingdom
Else Kröner-Fresenius-Foundation, Bad Homburg, Germany
Research Foundation - Flanders, Brussels, Belgium
Wilhelm Sander-Foundation, Munich, Germany
B. Braun Foundation, Melsungen, Germany
German Cancer Aid, Bonn, Germany
Bavarian Research Foundation, Munich
National Science Centre, Krakow, Poland
Czech Health Research Agency, Prague, Czech Republic
Netherlands Organization for Health Research and Development, Den Haag, The Netherlands
Swiss National Science Foundation, Division of Biology and Medicine, Bern, Switzerland
Italian Ministry of University and Research, Rome, Italy
Honorary professorships
2017
Zhejiang University, Huzhou, People’s Republic of China
Prof. hon.
2017
Dalian Medical University, People’s Republic of China
Visiting Professor (2017 – 2020)
2001
Yamanashi Medical University, Japan
Visiting Professor (2001)
Honorary doctorate
2016
Doctor Honoris Causa, Universitas Vilnensis, Lithuania
Awared for “outstanding research achievement in the fields of surgical oncology and visceral transplantology”
Professorships
2016 – 2023
Full Professor, Medical University Graz, Austria
2019 – 2023
Professor of Partnership, Universitas Vilnensis, Lithuania
Since 2007
Associate Professor, Ruprecht-Karls-University Heidelberg, Germany
Scientific publications
Number of publications
> 750
Number of citations
> 18.000
H-Index
68
Publicationas
Exemplary; see also https://pubmed.ncbi.nlm.nih.gov/?term=Schemmer+p&sort=date
Butkutė A., Jurkšas T., Baravykas T., Leber B., Merkininkaitė G., Žilėnaitė R., Čereška D., Gulla A., Kvietkauskas M., Marcinkevičiūtė K., Schemmer P., Strupas K. Combined femtosecond laser glass microprocessing for liver-on-chip device fabrication. Materials (Basel). 2023; 16(6): 2174
Jakubauskas M., Jakubauskiene L., Leber B., Horvath A., Strupas K., Stiegler P., Schemmer P. Probiotic supplementation attenuates chemotherapy-induced intestinal mucositis in an experimental colorectal cancer liver metastasis model. Nutrients 2023; 15(5): 1117
Jakubauskas M., Jakubauskiene L., Leber B., Horvath A., Strupas K., Stiegler P, Schemmer P. Probiotic supplementation suppresses tumor growth in an experimental colorectal cancer liver metastasis model. Int J Mol Sci 2022; 23(14): 7674
Čižauskaitė A., Šimčikas D., Schultze D., Kallifatidis G., Bruns H., Čekauskas A., Herr I., Baušys A., Strupas K., Schemmer P. Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells. Oncol Rep 2022; 48(5): 205
Wagner D., Haybaeck J., Wienerroither V., Bajric T., Tomberger A., Schemmer P., Mischinger H.J., Kornprat P. Platelet to lymphocyte ratio correlates with carcinoma progression in pancreatic intra epithelial neoplasia. Anticancer Res 2022; 42(3): 1413-1419
Kvietkauskas M., Zitkute V., Leber B., Strupas K., Stiegler P., Schemmer P. Dietary melatonin and glycine decrease tumor growth through antiangiogenic activity in experimental colorectal liver metastasis. Nutrients 2021; 13(6): 2035
Lozanovski V.J., Polychronidis G., Gross W., Gharabaghi N., Mehrabi A., Hackert T., Schemmer P.*, Herr I.* Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study. Invest New Drugs 2020; 38(3): 776-784; * shared senior author ship
Kniepeiss D., Talakić E., Schemmer P. Echinococcus granulosus: A novel parenchymal sparing surgical treatment. Hepatobiliary Pancreat Dis Int 2020; S1499-3872(20)30033-3. doi: 10.1016/j.hbpd.2020.02.003
Houben P., Hinz U., Knebel P., Diener M.K., Mehrabi A., Schemmer P. Randomized controlled trial on Pringle maneuver to reduce blood loss during stapler hepatectomy - PriMal StHep. BMC Surg 2019; 19(1): 60
Maneikyte J., Bausys A., Leber B., Horvath A., Feldbacher N., Hoefler G., Strupas K., Stiegler P., Schemmer P. Dietary glycine decreases both tumor volume and vascularization in a combined colorectal liver metastasis and chemotherapy model. Int J Biol Sci 2019; 15(5): 1582-1590
Al-Saeedi M., Nickkholgh A., Schultze D., Flechtenmacher C., Zorn M., Liang R., Gutt C.N., Schemmer P. Glycine protects the liver from reperfusion injury following pneumoperitoneum. Eur Surg Res 2018; 59(1-2): 91-99
Görtz M., Galli U., Longerich T., Zöller M., Erb U., Schemmer P. De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells. Oncol Rep 2017; 38(5): 2697-2704
Račkauskas R., Zhou D., Ūselis S., Strupas K., Herr I., Schemmer P. Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins. Oncol Rep 2017; 37(6): 3660-3666
Lin S., Hoffmann K., Gao C., Petrulionis M., Herr I., Schemmer P. Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma. J Pineal Res 2017; 62(3). doi: 10.1111/jpi.12398
Bruns H., Kazanavicius D., Schultze D., Saeedi M.A., Yamanaka K., Strupas K., Schemmer P. Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. Amino Acids 2016; 48(11): 2549-2558
Hoffmann K., Bulut S., Tekbas A., Hinz U., Büchler M.W., Schemmer P. Is hepatic resection for non-colorectal non-neuroendocrine liver metastases justified? Ann Surg Oncol 2015; 22(Suppl 3): 1083-1092
Kremer M., Manzini G., Hristov B., Polychronidis G., Mokry T., Sommer C.M., Mehrabi A., Weitz J., Büchler M.W., Schemmer P. Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after ALPPS. J Am Coll Surg 2015; 221(3): 717-728
Hoffmann K., Luible S., Goeppert B., Hinz U., Büchler M.W., Schemmer P. Impact of portal vein resection on oncological long-term outcome in patients with hilar cholangiocarcinoma. Surgery 2015; 158(5): 1252-1260
Hoffmann K., Müller-Bütow V., Franz C., Hinz U., Longerich T., Büchler M.W., Schemmer P. Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: a multivariate, single-center analysis. Anticancer Res 2014; 34(2): 767-776
Bruns H., Petrulionis M., Schultze D., Al Saeedi M., Lin S., Yamanaka K., Ambrazevičius M., Strupas K., Schemmer P. Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells. Amino Acids 2014; 46(4): 969-976
Hackert T., Lozanovski V.J., Werner J., Büchler M.W., Schemmer P. Teres hepatis ligament flap plasty to prevent pancreatic fistula after tumor enucleation. J Am Coll Surg 2013; 217(4): e29-34
Nickkholgh A., Schneider H., Sobirey M., Venetz W.P., Hinz U., Pelzl H., Gotthardt D.N., Cekauskas A., Manikas M., Mikalauskas S., Mikalauskene L., Bruns H., Zorn M., Weigand M.A., Büchler M.W., Schemmer P. The use of high-dose melatonin in liver resection is safe: first clinical experience. J Pineal Res 2011; 50(4): 381-388
Ceyhan G.O., Timm A.K., Bergmann F., Günther A., Aghdassi A.A., Demir I.E., Mayerle J., Kern M., Lerch M.M., Büchler M.W., Friess H., Schemmer P. Prophylactic glycine administration attenuates pancreatic damage and inflammation in experimental acute pancreatitis. Pancreatology 2011; 11(1): 57-6
Mikalauskas S., Mikalauskiene L., Bruns H., Nickkholgh A., Hoffmann K., Longerich T., Strupas K., Büchler M.W., Schemmer P. Dietary glycine protects from chemotherapy-induced hepatotoxicity. Amino Acids 2011; 40(4): 1139-11507
Schemmer P., Schultze D.P., Contin P., Seiler C.M., Seitz H.K., Weitz J., Büchler M.W. Antireflux jejunoplasty for recurrent cholangitis. J Am Coll Surg 2011; 212(5): e28-32wa
Bruns H., Krätschmer K., Hinz U., Brechtel A., Keller M., Büchler M.W., Schemmer P. Quality of life after curative liver resection: A single center analysis. World J Gastroenterol 2010; 16(19): 2388-2395
Hoffmann K., Franz C., Hinz U., Schirmacher P., Herfarth C., Eichbaum M., Büchler M.W., Schemmer P. Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol 2010; 17(6): 1546-1554
THE TEAM OF THE PANCREAS CLINIC SWITZERLAND
Enquiries and contact
Prof. Dr. med. Dr. h.c. Peter Schemmer and his team look forward to welcoming you to the Pancreas Clinic Switzerland. If you are unsure about our services or have any other questions, we are at your disposal: Get in touch.